Home » Stocks » ObsEva

ObsEva SA (OBSV)

Stock Price: $2.66 USD -0.13 (-4.66%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed
After-hours: $2.68 +0.02 (0.75%) Jul 10, 7:47 PM

Stock Price Chart

Key Info

Market Cap 137.99M
Revenue (ttm) 15,000
Net Income (ttm) -108.79M
Shares Out 44.59M
EPS (ttm) -2.38
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $2.66
Previous Close $2.79
Change ($) -0.13
Change (%) -4.66%
Day's Open 2.85
Day's Range 2.65 - 2.85
Day's Volume 1,424,720
52-Week Range 1.63 - 11.08

More Stats

Market Cap 137.99M
Enterprise Value 95.70M
Earnings Date (est) Aug 5, 2020
Ex-Dividend Date n/a
Shares Outstanding 44.59M
Float 27.40M
EPS (basic) -2.49
EPS (diluted) -2.38
FCF / Share -1.99
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 685,835
Short Ratio 0.86
Short % of Float 2.34%
Beta 1.10
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 9,199.34
PB Ratio 3.44
Revenue 15,000
Operating Income -107.11M
Net Income -108.79M
Free Cash Flow -90.66M
Net Cash 42.29M
Net Cash / Share 0.82
Gross Margin 106.67%
Operating Margin -714,073.33%
Profit Margin n/a
FCF Margin -604,380.00%
ROA -52.15%
ROE -128.98%
ROIC -3,640.90%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (8)

Buy 5
Overweight 0
Hold 3
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$13.38*
(403.01% upside)
Low
4.00
Current: 2.66
High
36.00
Target: 13.38
*Average 12-month price target from 8 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year201920182017201620152014
Revenue------
Operating Income-107-77.17-67.48-30.16-19.85-12.92
Net Income-109-76.72-66.93-30.20-19.87-12.81
Shares Outstanding45.4837.1323.1822.3622.36-
Earnings Per Share-2.49-1.91-2.25-1.40-1.87-1.41
Operating Cash Flow-90.61-63.94-55.72-28.59-13.91-12.12
Capital Expenditures-0.05-0.19-0.19-0.05-0.05-0.10
Free Cash Flow-90.66-64.13-55.90-28.63-13.96-12.23
Cash & Equivalents69.3713911125.5154.284.01
Total Debt27.08-----
Net Cash / Debt42.2913911125.5154.284.01
Assets10416713545.5371.599.28
Liabilities54.9920.5212.589.486.923.29
Book Value48.9614712336.0464.685.99
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name ObsEva SA
Country Switzerland
Employees 53
CEO Ernest Loumaye

Stock Information

Ticker Symbol OBSV
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: OBSV
IPO Date January 26, 2017

Description

ObsEva SA, a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. The company is developing Linzagolix, an oral gonadotropin-releasing hormone receptor antagonist for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. It also is developing OBE022, an oral and selective prostaglandin F2a, or PGF2a receptor antagonist, as a once daily treatment for preterm labor in weeks 24 to 34 of gestational age; and Nolasiban, an oral oxytocin receptor antagonist to enhance clinical pregnancy and live birth rates in women undergoing in vitro fertilization. The company was founded in 2012 and is headquartered in Geneva, Switzerland.